(Q49327827)

20 February 2018

title

A phase II trial of D-Trp-6-LHRH (decapeptyl) in pretreated patients with advanced epithelial ovarian cancer (English)

1 reference

20 February 2018

main subject

phase II clinical trial

0 references

1 reference

Ron IG

1

1 reference

20 February 2018

Wigler N

2

1 reference

20 February 2018

Merimsky O

3

1 reference

20 February 2018

Inbar MJ

4

1 reference

20 February 2018

Chaitchik S

5

1 reference

20 February 2018

publication date

1 January 1995

1 reference

20 February 2018

published in

Cancer Investigation

1 reference

20 February 2018

volume

13

1 reference

20 February 2018

issue

3

1 reference

20 February 2018

page(s)

272-275

1 reference

20 February 2018

LHRH-receptors and LHRH-agonist treatment in ovarian cancer: an overview

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357909509094461

Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509094461

Treatment of advanced refractory ovarian carcinoma with a gonadotropin-releasing hormone analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509094461

A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509094461

Absence of gonadotropin-releasing hormone receptors in human gonadal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509094461

An immunohistochemical study of the incidence and significance of human gonadotrophin and prolactin binding sites in normal and neoplastic human ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509094461

10.3109/07357909509094461

21 January 2018

Identifiers

DOI

1 reference

20 February 2018

1 reference

20 February 2018